Sheng Zhong, Ph.D.
Professor
Shu Chien-Gene Lay Department of Bioengineering
University of California, San Diego
Seminar Information
Artificial Intelligence (AI) has experienced cycles of enthusiasm and skepticism throughout its history. Today, AI is actively transforming biomedical research. This seminar will provide historical context on AI's evolution, emphasizing key milestones in biology and medicine. Recent advances from our laboratory, such as AI-driven blood-based diagnostics for early disease detection and innovative therapeutic strategies targeting Alzheimer's disease, will be presented as illustrative examples.
Sheng Zhong completed his training at Peking University and Stanford University, earning his Ph.D. from Harvard University. He is currently a Professor at the University of California, San Diego, where he directs the Center for Liquid Biopsy Research, serves as the organizational hub leader for the NIH-funded 4D Nucleome (4DN) Program, and leads a Transformative Technology Development team within the Human BioMolecular Atlas Program (HuBMAP). Dr. Zhong's work has been recognized with the NIH Director's Pioneer Award and the NIDDK Catalyst Award. He is a fellow of both the American Institute for Medical and Biological Engineering (AIMBE) and the Asia-Pacific Artificial Intelligence Association (AAIA). Nine of his trainees are currently contributing to science and engineering as tenure-track faculty.